About
The successful treatment attempt of a glaucoma patient with Long COVID with an infusion of an aptamer (BC 007) provides the basis for the assumption that autoantibodies against G protein-coupled receptors (GPCR-AAb) may play a significant role in the pathogenesis of Long COVID. BC007 binds and neutralises the SARS-CoV-2-triggered formation of GPCR-AAb, which has been observed in the serum of patients with Long COVID and shows a relationship to microcirculation in a disease model (glaucoma).
Based on this clinical observation, the sub-project will expand on the clinical cohort of the previous reCOVer study by correlating microcirculatory properties with blood rheology and single-cell mechanics of the blood cells. Furthermore, a rapid test for the presence of GPCR-AAbs in patient serum will be developed, and possible changes at the endothelial level caused by the GPCR-AAb will be molecularly investigated.
Description adapted from project website: see link above.
Not available.
Patients enrolled: Not available
Age group: Not available